GRASTEK
Biological
Merck Sharp & Dohme Corporation
Total Payments
$45,341
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $45,341 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $44,345 | 1 | 97.8% |
| Travel and Lodging | $996.24 | 2 | 2.2% |
Payments by Type
Research
$44,345
1 transactions
General
$996.24
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Desensitization and Cross-Desensitization during Oral Grass or Ragweed Pollen Immunotherapy | Merck Sharp & Dohme Corporation | $44,345 | 0 |
Top Doctors Receiving Payments for GRASTEK
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Richmond, VA | $44,345 | 1 |
| , MD | Allergy & Immunology | Blue Bell, PA | $996.24 | 2 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme Corporation $45,341
Product Information
- Type Biological
- Total Payments $45,341
- Total Doctors 1
- Transactions 3
About GRASTEK
GRASTEK is a biological associated with $45,341 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2017 to 2017. In 2017, $45,341 was paid across 3 transactions to 1 doctors.
The most common payment nature for GRASTEK is "Unspecified" ($44,345, 97.8% of total).
GRASTEK is associated with 1 research study, including "Desensitization and Cross-Desensitization during Oral Grass or Ragweed Pollen Immunotherapy" ($44,345).